Juan Macias Sanchez

Profesor Asociado CIS
jmacias7@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Grupo Virología Clínica e ITS (CTS-1095)
Tipo Año Título Fuente
Artículo2021 Exploring and understanding HCV patient journeys- HEPCARE Europe project BMC INFECTIOUS DISEASES
Artículo2021 Impact of recent drug use on the efficacy of Elbasvir/Grazoprevir for HCV-infected people on opioid agonist therapy. JOURNAL OF VIRAL HEPATITIS
Artículo2021 Liver stiffness-based strategies predict absence of variceal bleeding in cirrhotic hepatitis C virus-infected patients with and without human immunodeficiency virus coinfection after sustained virological response. CLINICAL INFECTIOUS DISEASES
Artículo2021 Long runs of homozygosity are associated with Alzheimer’s disease TRANSLATIONAL PSYCHIATRY
Artículo2021 Reply to Giannini et al. CLINICAL INFECTIOUS DISEASES
Artículo2021 Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy. PLOS ONE
Artículo2020 Cryptococcal infection in HIV-infected patients with CD4+ T-cell counts under 100/μL diagnosed in a high-income country: a multicentre cohort study CLINICAL MICROBIOLOGY AND INFECTION
Otros2020 Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2020 Hepatitis E 3ra genotype infection in people living with HIV in Spain FRONTIERS IN MICROBIOLOGY
Artículo2020 HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2020 HepCare Europe—A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2020 High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment SCIENTIFIC REPORTS
Artículo2020 Impact of HIV on the survival of hepatocellular carcinoma in hepatitis C virus-infected patients AIDS
Artículo2020 Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain HIV MEDICINE
Artículo2020 Liver stiffness at the time of sustained virological response predicts the clinical outcome in people living with human immunodeficiency virus and hepatitis C virus with advanced fibrosis treated with direct-acting antivirals CLINICAL INFECTIOUS DISEASES
Artículo2020 Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease CLINICAL INFECTIOUS DISEASES
Letter2020 Progression to hepatitis C virus micro-elimination in people living with HIV in Spain CLINICAL MICROBIOLOGY AND INFECTION
Artículo2020 Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection SCIENTIFIC REPORTS
Artículo2020 What is needed to achieve HCV microelimination among HIV-infected populations in Andalusia, Spain: a modeling analysis BMC INFECTIOUS DISEASES
Artículo2019 A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study) LIVER INTERNATIONAL
Artículo2019 Early emergence of opportunistic infections after starting direct-acting antiviral drugs in HIV/HCV-coinfected patients JOURNAL OF VIRAL HEPATITIS
Artículo2019 Genetic markers of lipid metabolism genes associated with low susceptibility to HCV infection SCIENTIFIC REPORTS
Artículo2019 Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project Alzheimer's & Dementia
Artículo2019 HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019 Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks JOURNAL OF INFECTION
Artículo2019 HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals AIDS
Artículo2019 Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019 Integrating primary and secondary care to optimize hepatitis C treatment: development and evaluation of a multidisciplinary educational Masterclass series JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019 Low performance of ultrasound surveillance for the diagnosis of hepatocellular carcinoma in HIV-infected patients AIDS
Artículo2019 Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV-infected patients HIV MEDICINE
Artículo2019 Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort PLOS ONE
Artículo2019 Response to direct-acting antiviral therapy among ongoing drug users and people receiving opioid substitution therapy JOURNAL OF HEPATOLOGY
Artículo2019 Similar recovery of liver function after response to all-oral HCV therapy in patients with cirrhosis with and without HIV coinfection JOURNAL OF VIRAL HEPATITIS
Artículo2019 The simplification of the diagnosis process of chronic hepatitis C is cost-effective strategy ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2018 Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients JOURNAL OF VIRAL HEPATITIS
Artículo2018 Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life SCIENTIFIC REPORTS
Otros2018 Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2018 Guía de tratamiento de la infección por virus de la hepatitis C. Asociación Española para el Estudio del Hígado (AEEH) GASTROENTEROLOGIA Y HEPATOLOGIA
Artículo2018 Hepatocellular carcinoma after sustained virological response with interferon-free regimens in HIV/hepatitis C virus-coinfected patients AIDS
Artículo2018 Hepcare Europe - bridging the gap in the treatment of hepatitis C: study protocol Expert Review of Gastroenterology and Hepatology
Artículo2018 Impact of interferon-free regimens on the glomerular filtration rate during treatment of chronic hepatitis C in a real-life cohort JOURNAL OF VIRAL HEPATITIS
Artículo2018 Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice HIV CLINICAL TRIALS
Artículo2018 Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease CLINICAL INFECTIOUS DISEASES
Artículo2017 Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients HIV MEDICINE
Artículo2017 High frequency of potential interactions between direct-acting antivirals and concomitant therapy in HIV/hepatitis C virus-coinfected patients in clinical practice HIV MEDICINE
Artículo2017 HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy PHARMACOGENOMICS JOURNAL
Letter2017 HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients PHARMACOGENOMICS JOURNAL
Artículo2017 Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2017 Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis AIDS
Letter2017 Low incidence of acute hepatitis C virus infection among Southern Spanish HIV-infected individuals JOURNAL OF INFECTION
Revisión2017 Non-Alcoholic Fatty Liver Disease in HIV Infection AIDS REVIEWS
Artículo2016 Changes in the response to treatment against chronic hepatitis C between 1999 and 2015: data from a prospective cohort EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Revisión2016 HCV epidemiology in high-risk groups and the risk of reinfection JOURNAL OF HEPATOLOGY
Artículo2016 Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study PLOS ONE
Artículo2016 MicroRNA Profile in CD8+T-Lymphocytes from HIV-Infected Individuals: Relationship with Antiviral Immune Response and Disease Progression PLOS ONE
Artículo2016 No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014 BMC INFECTIOUS DISEASES
Artículo2016 The PNPLA3 genetic variant rs738409 influences the progression to cirrhosis in HIV/Hepatitis C virus coinfected patients PLOS ONE
Artículo2015 Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection Genes & Immunity
Artículo2015 Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C JOURNAL OF INFECTION
Artículo2015 High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Letter2015 IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection AIDS
Artículo2015 Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals AIDS
Artículo2015 Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection PLOS ONE
Artículo2015 Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term HEPATOLOGY
Artículo2015 Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis BMC INFECTIOUS DISEASES
Artículo2014 A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers LIVER INTERNATIONAL
Artículo2014 Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection ARCHIVES OF VIROLOGY
Artículo2014 Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting HIV MEDICINE
Artículo2014 IFNL4 ss469415590 Variant Shows Similar Performance to rs12979860 as Predictor of Response to Treatment against Hepatitis C Virus Genotype 1 or 4 in Caucasians PLOS ONE
Artículo2014 Incidence and natural history of hepatitis E virus coinfection among HIV-infected patients AIDS
Artículo2014 Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions PLOS ONE
Revisión2014 Latest pharmacotherapy options for treating hepatitis C in HIV-infected patients EXPERT OPINION ON PHARMACOTHERAPY
Artículo2014 Prevalence and factors associated with liver steatosis as measured by transient elastography with controlled attenuation parameter in HIV-infected patients AIDS
Artículo2014 Reassessment of genotype 1 hepatitis C virus subtype misclassification by LiPA 2.0: implications for direct-acting antiviral treatment JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2014 Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy JOURNAL OF INFECTION
Artículo2013 A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2013 Baseline risk factors for relapse in HIV/HCV co-infected patients treated with PEG-IFN/RBV INFECTION
Artículo2013 Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2013 Chronic Hepatitis E in HIV Patients: Rapid Progression to Cirrhosis and Response to Oral Ribavirin CLINICAL INFECTIOUS DISEASES
Artículo2013 Effects of the genetic pattern defined by low-density lipoprotein receptor and IL28B genotypes on the outcome of hepatitis C virus infection EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2013 Endoplasmic reticulum aminopeptidase 2 haplotypes play a role in modulating susceptibility to HIV infection AIDS
Artículo2013 Incidence of liver damage of uncertain origin in HIV patients not co-infected with HCV/HBV PLOS ONE
Artículo2013 Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2013 Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients AIDS
Artículo2013 Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response JOURNAL OF INFECTION
Artículo2013 Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy CLINICAL INFECTIOUS DISEASES
Artículo2013 Safety and efficacy of telaprevir in patients with HIV and hepatitis C virus coinfection ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2013 Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2013 Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection AIDS
Artículo2012 A Common Polymorphism in TLR3 Confers Natural Resistance to HIV-1 Infection JOURNAL OF IMMUNOLOGY
Artículo2012 Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2012 Genetic variability at the TREX1 locus is not associated with natural resistance to HIV-1 infection AIDS
Artículo2012 Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis JOURNAL OF INFECTION
Artículo2012 Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients HEPATOLOGY
Artículo2012 Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients AIDS
Artículo2012 HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection ANTIVIRAL RESEARCH
Artículo2012 Lack of short-term increase in serum mediators of fibrogenesis and in non-invasive markers of liver fibrosis in HIV/hepatitis C virus-coinfected patients starting maraviroc-based antiretroviral therapy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Letter2012 Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosis LIVER INTERNATIONAL
Artículo2012 Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis HEPATOLOGY
Artículo2012 Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients HIV CLINICAL TRIALS
Reseña2012 Low prevalence of occult HBV infection among HIV-infected patients in southern Spain ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2012 No influence of antiretroviral therapy on the mutation rate of the HCV NS5B polymerase in HIV/HCV-coinfected patients ANTIVIRAL RESEARCH
Artículo2012 Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load JOURNAL OF HEPATOLOGY
Artículo2012 Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2011 Combined use of aspartate aminotransferase, platelet count and matrix metalloproteinase 2 measurements to predict liver fibrosis in HIV/hepatitis C virus-coinfected patients HIV MEDICINE
Artículo2011 Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype HIV MEDICINE
Artículo2011 Host genetics CURRENT OPINION IN HIV AND AIDS
Artículo2011 Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011 Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011 Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011 Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients AIDS Patient Care and ST Ds
Artículo2011 Low-density lipoprotein receptor genotyping enhances the predictive value of IL28B genotype in HIV/hepatitis C virus-coinfected patients AIDS
Artículo2011 Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2010 Haart and the liver: friend or foe? EUROPEAN JOURNAL OF MEDICAL RESEARCH
Artículo2010 Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004-2008 MEDICINA CLINICA
Artículo2010 Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Artículo2010 Modeling the Probability of Sustained Virological Response to Therapy with Pegylated Interferon plus Ribavirin in Patients Coinfected with Hepatitis C Virus and HIV CLINICAL INFECTIOUS DISEASES
Artículo2010 Prediction of Response to Pegylated Interferon plus Ribavirin by IL28B Gene Variation in Patients Coinfected with HIV and Hepatitis C Virus CLINICAL INFECTIOUS DISEASES
Artículo2010 Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients JOURNAL OF VIRAL HEPATITIS
Artículo2010 Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine ANTIVIRAL THERAPY
Artículo2010 Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice HIV MEDICINE
Revisión2009 A review of current anti-HCV treatment regimens and possible future strategies EXPERT OPINION ON PHARMACOTHERAPY
Artículo2009 Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus-Coinfected Patients with Advanced Immunosuppression CLINICAL INFECTIOUS DISEASES
Artículo2009 Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus HEPATOLOGY
Artículo2009 Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2009 Impact of Observer Experience on the Reproducibility of Transient Elastometry in HIV/HCV Co-infected Patients HIV CLINICAL TRIALS
Artículo2009 Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients GUT
Artículo2009 Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients JOURNAL OF HEPATOLOGY
Artículo2009 Liver Stiffness as a Predictor of Esophageal Varices Requiring Therapy in HIV/Hepatitis C Virus-Coinfected Patients With Cirrhosis JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2009 Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients CLINICAL INFECTIOUS DISEASES
Artículo2009 Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation ANTIVIRAL THERAPY
Artículo2008 Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients JOURNAL OF HEPATOLOGY
Artículo2008 Changes in liver-related hospital admissions and hospital mortality among HIV-infected patients (1998 to 2005) ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2008 Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack LIVER INTERNATIONAL
Artículo2008 Liver toxicity of antiretroviral combinations including atazanavir/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of pre-existing liver fibrosis JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users JOURNAL OF INFECTIOUS DISEASES
Artículo2007 Clinical progression of hepatitis C virus - Related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active Antiretroviral therapy HEPATOLOGY
Artículo2007 Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007 Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2007 Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2007 The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection CLINICAL INFECTIOUS DISEASES
Artículo2006 Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C ANTIVIRAL THERAPY
Artículo2006 Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2006 Incidence of and risk factors for insulin resistance in treatment-naive HIV-infected patients 48 weeks after starting highly active antiretroviral therapy ANTIVIRAL THERAPY
Artículo2006 Incidence of and risk factors for severe hepatotoxicity of nelfinavir-containing regimens among HIV-infected patients with chronic hepatitis C JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006 Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients JOURNAL OF VIRAL HEPATITIS
Artículo2006 Low incidence of severe liver events in HIV patients with and without hepatitis C or B coinfection receiving lopinavir/ritonavir HIV CLINICAL TRIALS
Artículo2006 Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple non-invasive indexes GUT
Artículo2006 Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease AIDS
Artículo2006 Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients JOURNAL OF CLINICAL MICROBIOLOGY
Letter2005 Antiretroviral therapy and liver fibrosis in HIV-infected patients with chronic hepatitis C HEPATOLOGY
Artículo2005 Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection JOURNAL OF INFECTIOUS DISEASES
Artículo2005 Prevalencia de anticuerpos séricos frente a Bartonella spp. en una población sana del área sur de la provincia de Sevilla REVISTA CLINICA ESPANOLA
Artículo2005 Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2005 Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2005 Transient rebounds of hiv plasma vieremia are associated with the emergence of drug resistance mutations in patients on highly active antiretroviral therapy JOURNAL OF INFECTION
Artículo2004 Bilateral enophthalmos as a manifestation of HIV infection-related lipoatrophy HIV MEDICINE
Artículo2004 Detection of Leishmania infantum kinetoplast DNA in peripheral blood from asymptomatic individuals at risk for parenterally transmitted infections: Relationship between polymerase chain reaction results and other Leishmania infection markers AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Artículo2004 Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C: harmful impact of nevirapine AIDS
Artículo2004 Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Artículo2004 Gynaecomastia in HIV-infected men on highly active antiretroviral therapy: association with efavirenz and didanosine treatment ANTIVIRAL THERAPY
Letter2004 Prevalence of non-significant liver fibrosis and rate of fibrosis progression in HIV/hepatitis C virus-co-infected patients: still a role for liver biopsy? AIDS
Artículo2003 Bone involvement and abcess formation by neutrophil-rich CD30+anaplastic large-cell lymphoma mimicking skeletal infection in an AIDS patient JOURNAL OF INFECTION
Artículo2003 Impaired recovery of CD4+cell counts following highly active antiretroviral therapy in drug-naive patients coinfected with human immunodeficiency virus and hepatitis C virus EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2003 Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum beta 2microglobulin levels EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2003 Kinetics of Bartonella spp. IgG antibodies in cat-scratch disease and in asymptomatic HIV-infected patients MEDICINA CLINICA
Artículo2003 Necrotizing granulomatous vasculitis in advanced HIV infection JOURNAL OF INFECTION
Artículo2003 Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients HIV CLINICAL TRIALS
Artículo2002 Efecto del tratamiento antirretroviral de gran actividad sobre la forma de presentación del sida definido por episodios clínicos MEDICINA CLINICA
Artículo2002 Incidence of and risk factors for symptomatic visceral leishmaniasis among human immunodeficiency virus type 1-infected patients from Spain in the era of highly active antiretroviral therapy JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2002 Leishmania infantum (Protozoa, Kinetoplastida): transmission from infected patients to experimental animal under conditions that simulate needle-sharing EXPERIMENTAL PARASITOLOGY
Letter2002 Leishmania spp infection in injecting drug users LANCET
Artículo2002 Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2002 Prevalencia de seropositividad para Bartonella spp. en pacientes adictos a drogas por vía parenteral infectados y no infectados por el virus de la inmunodeficiencia humana MEDICINA CLINICA
Artículo2002 The high sensitivity of a PCR-ELISA in the diagnosis of cutaneous and visceral leishmaniasis caused by Leishmania infantum ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
Artículo2002 Transient rebounds of low-level viraemia among HIV-infected patients under HAART are not associated with virological or immunological failure ANTIVIRAL THERAPY
Artículo2001 Evidence of increased risk for Leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Editorial2001 False-positive results of leishmanin skin test due to phenol-containing diluent TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Artículo2001 HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Letter2001 HIV-1 progression in hepatitis-C-infected drug users LANCET
Letter2001 HIV-1 progression in hepatitis-C-infected drug users [3] (multiple letters) LANCET
Artículo2001 Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients CLINICAL INFECTIOUS DISEASES
Artículo2001 Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype B and advanced immunosuppression JOURNAL OF INFECTION
Artículo2001 Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood Liver
Artículo2001 Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy AIDS
Artículo2001 Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4+ T-cell counts EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2000 CD4(+) and CD8(+) T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Artículo1999 Colestasis disociada en pacientes infectados por el VIH-1. Prevalencia y valor diagnóstico de la biopsia hepática REVISTA CLINICA ESPANOLA
Artículo1999 High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Letter1999 Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine JOURNAL OF HEPATOLOGY
Artículo1999 Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Letter1999 The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection MEDICINA CLINICA
Letter1999 The clinical impact of symptomatic visceral leishmaniasis on the outcome of HIV-1 infection MEDICINA CLINICA
Artículo1998 Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo1998 Influencia de la actuación médica sobre la forma de presentación del sida definido por episodios clínicos MEDICINA CLINICA
Artículo1998 Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients JOURNAL OF CLINICAL MICROBIOLOGY
Artículo1998 Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain JOURNAL OF CLINICAL MICROBIOLOGY
Artículo1998 Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy CLINICAL INFECTIOUS DISEASES
Letter1997 Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. AIDS
Artículo1997 Unexpected high prevalence of hepatitis C virus genotype 4 in southern Spain JOURNAL OF HEPATOLOGY
Letter1996 Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Editorial1996 Kala-azar in HIV infection: The tip of the iceberg? MEDICINA CLINICA
Artículo1996 Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1 TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
Letter1995 Granulomatous pneumonitis: A clinical manifestation and atypical pathology of pneumocystosis in AIDS MEDICINA CLINICA
Letter1995 Granulomatous pneumonitis: A clinical manifestation and atypical pathology of pneumocystosis in AIDS [1] MEDICINA CLINICA

Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado